Latest filing published 16 Mar 2021 for Prometheus Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -5.7%Entry US$412.00 · Close at T+365 US$388.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tadataka Yamada: trading record in brief
Tadataka Yamada discloses dealings in 4 companies, chiefly Agilent Technologies, Inc., Covidien Ltd. and Passage BIO, Inc. In total, 43 filings cover trades dated from 2 July 2007 to 16 March 2021.
Purchases make up the whole of the open-market record (1 purchase, €105k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 40 share grants.
The latest filing, published on 16 March 2021, reports a transaction in Prometheus Biosciences, Inc. The latest purchase dates back some time: it was published 2,442 days ago, on 3 March 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tadataka Yamada
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,333 sharesCommon StockSEC:0001209191-21-021221:0
- 212 shares@ US$93.915.5% of flowCommon StockSEC:0001127602-20-022977:0
- 3,081 shares@ US$73.0167.5% of flowCommon StockSEC:0001127602-20-014252:0
- 1,027 shares@ US$73.0122.5% of flowCommon StockSEC:0001127602-20-014252:1
- 205 shares@ US$73.014.5% of flowCommon StockSEC:0001127602-20-014252:2
- 6,500 shares@ US$18.00100.0% of flowCommon StockSEC:0001209191-20-015648:0Canonical exit: 1 Jun 2020 (T+90)
- 2,823 shares@ US$82.0032.8% of flowCommon StockSEC:0001127602-19-012835:0
- 1,254.87 shares@ US$82.0014.6% of flowCommon StockSEC:0001127602-19-012835:1
- 250.97 shares@ US$82.002.9% of flowCommon StockSEC:0001127602-19-012835:2
- 2,876 shares@ US$67.4711.1% of flowCommon StockSEC:0001127602-18-012676:0
- 287.61 shares@ US$67.471.1% of flowCommon StockSEC:0001127602-18-012676:1
- 1,438.06 shares@ US$67.475.5% of flowCommon StockSEC:0001127602-18-012676:2
- 3,866 shares@ US$53.0513.4% of flowCommon StockSEC:0001127602-17-012254:0
- 1,933.19 shares@ US$53.056.7% of flowCommon StockSEC:0001127602-17-012254:1
- 386.64 shares@ US$53.051.3% of flowCommon StockSEC:0001127602-17-012254:2
- 4,704 shares@ US$39.2911.6% of flowCommon StockSEC:0001127602-16-046969:0
- 2,352.33 shares@ US$39.295.8% of flowCommon StockSEC:0001127602-16-046969:1
- 2,125.15 shares@ US$41.65Common StockSEC:0001127602-13-011921:1
- 2,642 shares0Ordinary SharesSEC:0001225208-11-009981:0
- 11 shares0Ordinary SharesSEC:0001225208-11-006848:0
- 477 shares@ US$42.97Common StockSEC:0001127602-11-001791:0
- 13 shares0Ordinary SharesSEC:0001225208-10-024646:0
- 13 shares0Ordinary SharesSEC:0001181431-10-043705:0
- 10 shares0Ordinary SharesSEC:0001225208-10-013358:0
- 2,681 shares0Ordinary SharesSEC:0001225208-10-008565:0
25 of 34 declarations
